M2-Deficient Single-Replication Influenza Vaccine–Induced Immune Responses Associated With Protection Against Human Challenge With Highly Drifted H3N2 Influenza Strain
Abstract
Current influenza vaccines are strain specific and demonstrate low vaccine efficacy against H3N2 influenza disease, especially when vaccine is mismatched to circulating virus. The novel influenza vaccine candidate, M2-deficient single replication (M2SR), induces a broad, multi-effector immune response.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jul 29, 2021
- Source ID
- 10.1093/infdis/jiab374
Entities
People
- Bram Volckaert
- David Marshall
- Gabriele Neumann
- Harry B. Greenberg
- Joseph Eiden
- Kathleen Coelingh
- Oleg Rudenko
- Pamuk Bilsel
- Renee Herber
- Robert Belshe
- Roger Aitchison
- Yoshihiro Kawaoka
Organizations
- FluGen
- Saint Louis University
- Stanford University
- University of Wisconsin–Madison